These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24972844)

  • 41. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with inherited thrombophilias.
    Warren JE; Simonsen SE; Branch DW; Porter TF; Silver RM
    Am J Obstet Gynecol; 2009 Mar; 200(3):281.e1-5. PubMed ID: 19114274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss.
    Rottenstreich A; Amsalem H; Kleinstern G; Kalish Y
    Reprod Biomed Online; 2017 Oct; 35(4):461-467. PubMed ID: 28756129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testing for inherited thrombophilia in recurrent miscarriage.
    de Jong PG; Goddijn M; Middeldorp S
    Semin Reprod Med; 2011 Nov; 29(6):540-7. PubMed ID: 22161466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment and management of high-risk pregnancies in women with thrombophilia.
    Sarig G; Vidergor G; Brenner B
    Blood Rev; 2009 Jul; 23(4):143-7. PubMed ID: 19135285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylaxis and treatment of thrombophilia in pregnancy.
    Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
    Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The potential role of heparin in assisted conception.
    Nelson SM; Greer IA
    Hum Reprod Update; 2008; 14(6):623-45. PubMed ID: 18701511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calibrated Automated Thrombogram During Pregnancy in Unexplained Recurrent Miscarriages: A Pilot Study.
    Elias A; Hamoudi R; Schwartz N; Ron G; Elias M
    Isr Med Assoc J; 2019 Oct; 21(10):681-685. PubMed ID: 31599511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reproductive Failure and Thrombophilia: Not Enough Evidence for a Tight Bond.
    Stamou M; Intzes S; Symeonidou M; Bazntiara I; Bezirgiannidou Z; Pentidou A; Misidou C; Liapis K; Margaritis D; Kotsianidis I; Spanoudakis E
    Acta Haematol; 2022; 145(2):170-175. PubMed ID: 34879375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
    Galambosi PJ; Ulander VM; Kaaja RJ
    Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Birth outcomes in pregnant women treated with low-molecular-weight heparin.
    Sørensen HT; Johnsen SP; Larsen H; Pedersen L; Nielsen GL; Møller M
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):655-9. PubMed ID: 10949230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of pregnancies in women with thrombophilic disorders.
    Sucak A; Acar K; Celen S; Danisman N; Sucak GT
    J Obstet Gynaecol; 2010; 30(8):847-51. PubMed ID: 21126128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Risk pregnancies and how to treat them].
    Kiesewetter H; Radtke H; Becker R; Schmidt FP; Körber K; Vehlow N
    Hamostaseologie; 2012; 32 Suppl 1():S90-4. PubMed ID: 22960791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of anti-thrombotic therapy for recurrent pregnancy loss due to anti-phospholipid syndrome.
    Fawad S
    J Ayub Med Coll Abbottabad; 2010; 22(3):197-200. PubMed ID: 22338455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assisted reproductive technology surveillance--United States, 2001.
    Wright VC; Schieve LA; Reynolds MA; Jeng G; Kissin D
    MMWR Surveill Summ; 2004 Apr; 53(1):1-20. PubMed ID: 15123982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies.
    Goel N; Tuli A; Choudhry R
    Med Sci Monit; 2006 Mar; 12(3):CR132-6. PubMed ID: 16501426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of heterotopic and intrauterine-only pregnancy outcomes after assisted reproductive technologies in the United States from 1999 to 2002.
    Clayton HB; Schieve LA; Peterson HB; Jamieson DJ; Reynolds MA; Wright VC
    Fertil Steril; 2007 Feb; 87(2):303-9. PubMed ID: 17113092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assisted reproductive technology surveillance--United States, 2005.
    Wright VC; Chang J; Jeng G; Macaluso M;
    MMWR Surveill Summ; 2008 Jun; 57(5):1-23. PubMed ID: 18566567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does low molecular weight heparin influence the triple test result in pregnant women with thrombophilia?
    Wiener Y; Frank M; Neeman O; Kurzweil Y; Bar J; Maymon R
    Isr Med Assoc J; 2012 Apr; 14(4):247-50. PubMed ID: 22675844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.